Position in ANNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,734,597
+$3,940,225 QoQ
Shares Held
1,004,308
+210.1% QoQ
Ownership
0.491%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ANNX ranks #105 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,734,597 | 1,004,308 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,794,372 | 323,894 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $269,719 | 53,729 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $143,001 | 46,886 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $126,765 | 52,819 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,763,691 | 1,431,965 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,754,080 | 1,511,517 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,100,596 | 1,706,182 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $8,263,222 | 1,686,372 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $6,880,674 | 959,648 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $134,315 | 29,585 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $93,500 | 39,619 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $134,255 | 38,141 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,614 | 1,718 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $164,002 | 31,722 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $160,778 | 26,016 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $728,488 | 193,233 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $248,674 | 91,090 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $844,973 | 73,540 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,322,741 | 71,077 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $393,383 | 17,476 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $376,118 | 13,510 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $175,534 | 7,013 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $166,144 | 5,496 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||